Altorki NK, McGraw TE, Borczuk AC, Saxena A, et al. Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. Lancet Oncol 2021 May 17. pii: S1470-2045(21)00149.
PMID: 34015311